trending Market Intelligence /marketintelligence/en/news-insights/trending/DR4oyLkJE1w4BeZqzIG0FQ2 content esgSubNav
In This List

Biotechnology company Inscripta raises $125M in series D round

Video

S&P Capital IQ Pro | Powering Your Edge

Podcast

Street Talk Episode 81: Amid strong recovery, Banc of California hearing more M&A chatter

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Banking Essentials Newsletter: September Edition


Biotechnology company Inscripta raises $125M in series D round

Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.

New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.

Inscripta has now raised a total of $259.5 million.

Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.